TRANSLATIONAL ACCELERATOR
Translational Accelerator is a company that offers biomedical research and big data analytics services.
TRANSLATIONAL ACCELERATOR
Status:
Active
Similar Organizations
Sensus Retail
Sensus Retail is a company that uses communications technologies to data analytics and services.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2015-05-27 | Calimmune | Translational Accelerator investment in Series B - Calimmune | 15.85 M USD |
More informations about "Translational Accelerator"
The MND Translational Accelerator (MNDAcc)
Motor Neurone Disease is a life-shortening disease affecting 1 in 300 people. There is no known cure. The MND Translational Accelerator (MNDAcc) is a £6m investment by the Medical Research Council and the National Institute for …See details»
C-Path Launches Unique Translational Therapeutics …
Jun 9, 2022 The global accelerator will transform academic discoveries to drug development opportunities TUCSON, Ariz., June 9, 2022 — Critical Path Institute (C-Path) today announced it has been awarded a grant from the Frederick …See details»
C-Path’s TRxA Announces $750,000 in Research Awards to …
TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic …See details»
Brain Tumour Research Novel Therapeutics Accelerator (BTR-NTA)
Translational Therapeutics Accelerator (TRx) | Lab to …
Oct 29, 2024 Through our Translational Therapeutics (TRx) accelerator award, we focus on providing funding, education, partnership and mentorship to Columbia Investigators, with a goal of advancing novel therapies from the lab …See details»
Translational Therapeutics Accelerator
The Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is a global drug discovery and development program focused on supporting academic scientists in …See details»
C-Path launches unique translational therapeu
Jun 9, 2022 image: Translational Therapeutics Accelerator view more . Credit: Courtesy of C-Path. TUCSON, Ariz., June 9, 2022 — Critical Path Institute (C-Path) today announced it has been awarded a grant ...See details»
C-Path’s TRxA Announces 2025 Request for Proposals from …
Jan 14, 2025 New Funding Opportunity for Drug Development Projects. TUCSON, Ariz., January 14, 2025 – Critical Path Institute’s® (C-Path) Translational Therapeutics Accelerator (TRxA) …See details»
You can help advance drug development and improve …
Jan 22, 2024 About C-Path’s Translational Therapeutics Accelerator (TRxA) Critical Path Institute’s Translational Therapeutics Accelerator (TRxA) is a not-for-profit global drug accelerator focused on supporting academic scientists in …See details»
C-Path Launches Unique Translational Therapeutics …
Jun 9, 2022 "C-Path is exceptionally well-suited to offer a novel translational accelerator program that will support a comprehensive strategic approach for academic groups facing the valley of death ...See details»
C-Path’s TRxA announces $1 million award for | EurekAlert!
Nov 19, 2024 Critical Path Institute® today announced that its Translational Therapeutics Accelerator program, in partnership with The Leona M. and Harry B. Helmsley Charitable …See details»
Early Translation Accelerator | CCAMP
Early Translation Accelerator (ETA), is a programme under DIA, focusing on catalyzing transformation of young academic discoveries (publications/patents) with possible commercial …See details»
C-Path’s TRxA Accelerates its First Drug Development Projects with ...
TUCSON, Ariz., June 28, 2023 — Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) announced today its first two research grants supporting academic …See details»
Translational Medicine Accelerator (TMA)
To help close the gap between scientific research and use in practice, University Medicine Zurich (UMZH) is offering interested spin-offs an opportunity to improve their competitiveness with the …See details»
Translational Accelerator - Crunchbase Investor Profile
Translational Accelerator is a company that offers biomedical research and big data analytics services. Venture Capital 158,575; Highlights. Investments 1. obfuscated. Exits . Unlock for …See details»
C-Path Launches Unique Translational Therapeutics Accelerator …
Jun 9, 2022 The global accelerator will transform academic discoveries to drug development opportunities. TUCSON, Ariz., June 9, 2022 /PRNewswire/ -- Critical Path Institute (C-Path) …See details»
C-Path's TRxA Announces $250,000 Award for Drug Development …
Aug 8, 2024 Critical Path Institute’s Translational Therapeutics Accelerator (TRxA) is a global drug accelerator focused on supporting academic scientists in advancing novel therapeutics …See details»
A methodological framework for establishing a translational …
May 20, 2016 Background: MD Anderson Cancer Center seeks to leverage its considerable clinical and research enterprise by developing a Translational Research Accelerator (TRA) …See details»
Kissick Family Foundation Frontotemporal Dementia Grant Program
Sep 25, 2024 A list of voting board members and officers, as well as the name of the organization’s highest-ranking member (e.g., CEO). Additional organization governing …See details»
C-Path Launches Unique Translational Therapeutics Accelerator …
The global accelerator will transform academic discoveries to drug development opportunities. Tucson, AZ /PRNewswire/ - Critical Path Institute (C-Path) today announced it has been …See details»